Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce L Levine

Showing results (21-30 of 185) with videos related to

Pageof 19
Sort By:
Cytotherapy|February 17, 2019
Chimeric antigen receptor-T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goodsRichard P Harrison, Ezequiel Zylberberg, Simon Ellison, et al.
Cytotherapy|February 23, 2022
The peril of the promise of speculative cell banking: Statement from the ISCT Committee on the Ethics of Cell and Gene TherapyBruce L Levine, Megan Munsie, Aaron D Levine, et al.
Cancer Cell|February 27, 2026
Overcoming functional and translational challenges of cellular immunotherapies for solid tumorsYi-Ching Chen, Kok-Siong Chen, Bruce L Levine, et al.
Clinical Chemistry|July 21, 2023
In-Hospital Manufacturing of Cellular Therapies Using Automated SystemsStephan Kadauke, Martín H Bonamino, Bruce L Levine, et al.
Seminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.
Journal of Visualized Experiments : Jove|February 9, 2026
Efficient Production of Chimeric Antigen Receptor (CAR) T Cells with Transgenes Exceeding 10 kb Using Lentiviral VectorsPhilipp C Rommel, Nils W Engel, Bruce L Levine, et al.
The Lancet. Oncology|February 3, 2020
CAR T-cell product performance in haematological malignancies before and after marketing authorisationMagdi Elsallab, Bruce L Levine, Alan S Wayne, et al.
The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.
Cytotherapy|June 21, 2025
The next innovations in chimeric antigen receptor T cell immunotherapies for cancerKusala Anupindi, Julia Malachowski, Isabella Hodson, et al.
Stem Cells and Development|December 14, 2020
The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?Maroun Khoury, Laertis Ikonomou, Massimo Dominici, et al.
Pageof 19

Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
Cytotherapy|February 17, 2019
Chimeric antigen receptor-T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goodsRichard P Harrison, Ezequiel Zylberberg, Simon Ellison, et al.
Cytotherapy|February 23, 2022
The peril of the promise of speculative cell banking: Statement from the ISCT Committee on the Ethics of Cell and Gene TherapyBruce L Levine, Megan Munsie, Aaron D Levine, et al.
Cancer Cell|February 27, 2026
Overcoming functional and translational challenges of cellular immunotherapies for solid tumorsYi-Ching Chen, Kok-Siong Chen, Bruce L Levine, et al.
Clinical Chemistry|July 21, 2023
In-Hospital Manufacturing of Cellular Therapies Using Automated SystemsStephan Kadauke, Martín H Bonamino, Bruce L Levine, et al.
Seminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.
Journal of Visualized Experiments : Jove|February 9, 2026
Efficient Production of Chimeric Antigen Receptor (CAR) T Cells with Transgenes Exceeding 10 kb Using Lentiviral VectorsPhilipp C Rommel, Nils W Engel, Bruce L Levine, et al.
The Lancet. Oncology|February 3, 2020
CAR T-cell product performance in haematological malignancies before and after marketing authorisationMagdi Elsallab, Bruce L Levine, Alan S Wayne, et al.
The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.
Cytotherapy|June 21, 2025
The next innovations in chimeric antigen receptor T cell immunotherapies for cancerKusala Anupindi, Julia Malachowski, Isabella Hodson, et al.
Stem Cells and Development|December 14, 2020
The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?Maroun Khoury, Laertis Ikonomou, Massimo Dominici, et al.
Pageof 19